UnknownPhase 4NCT00265252

Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Principal Investigator
Gwo-Jaw Wang, MD
Kaohsiung Medical University
Intervention
Alendronate(drug)
Enrollment
60 enrolled
Eligibility
20-85 years · All sexes
Timeline
2005 – 2008

Study locations (1)

Collaborators

Merck Sharp & Dohme LLC · National Cheng-Kung University Hospital · National Taiwan University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00265252 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis →

← Back to all trials